These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 32855872)

  • 61. Corticosteroids in Moderate-To-Severe Graves' Ophthalmopathy: Oral or Intravenous Therapy?
    Penta L; Muzi G; Cofini M; Leonardi A; Lanciotti L; Esposito S
    Int J Environ Res Public Health; 2019 Jan; 16(1):. PubMed ID: 30626069
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A case of concurrent silent sinus syndrome, thyroid eye disease, idiopathic orbital inflammatory syndrome, and dacryoadenitis.
    Shieh WS; Huggins AB; Rabinowitz MR; Rosen MR; Rabinowitz MP
    Orbit; 2017 Dec; 36(6):462-464. PubMed ID: 28812921
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Immunological Aspects of Graves' Ophthalmopathy.
    Łacheta D; Miśkiewicz P; Głuszko A; Nowicka G; Struga M; Kantor I; Poślednik KB; Mirza S; Szczepański MJ
    Biomed Res Int; 2019; 2019():7453260. PubMed ID: 31781640
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Outcomes of endoscopic orbital decompression for graves' ophthalmopathy.
    Woods RSR; Pilson Q; Kharytaniuk N; Cassidy L; Khan R; Timon CVI
    Ir J Med Sci; 2020 Feb; 189(1):177-183. PubMed ID: 31203506
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Treatment of Grave's ophthalmopathy with high doses of corticosteroids].
    Cirić J; Zarković M; Stojanović M; Pepenezić Z; Randjelović G; Gligorović M; Trbojević B; Drezgić M; Nesović M
    Srp Arh Celok Lek; 2000; 128(5-6):179-83. PubMed ID: 11089418
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Modified orbital decompression for severe thyroid associated ophthalmopathy].
    Wang Y; Xiao LH; Yang ZK; Li YY
    Zhonghua Yan Ke Za Zhi; 2013 Mar; 49(3):242-9. PubMed ID: 23866706
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Pathophysiology of Graves' ophthalmopathy.
    Stiebel-Kalish H; Robenshtok E; Gaton DD
    Pediatr Endocrinol Rev; 2010 Mar; 7 Suppl 2():178-81. PubMed ID: 20467359
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Dysthyroid optic neuropathy: surgical treatment potential].
    Grusha YO; Ismailova DS; Kochetkov PA; Andreeva NA
    Vestn Oftalmol; 2020; 136(4. Vyp. 2):193-200. PubMed ID: 32880139
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Postoperative Changes in Strabismus, Ductions, Exophthalmometry, and Eyelid Retraction After Orbital Decompression for Thyroid Orbitopathy.
    Rootman DB; Golan S; Pavlovich P; Rootman J
    Ophthalmic Plast Reconstr Surg; 2017; 33(4):289-293. PubMed ID: 27487726
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Predictors of response to transantral orbital decompression in severe Graves' ophthalmopathy.
    Fatourechi V; Bergstralh EJ; Garrity JA; Bartley GB; Beatty CW; Offord KP; Gorman CA
    Mayo Clin Proc; 1994 Sep; 69(9):841-8. PubMed ID: 8065185
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Endoscopic orbital decompression for thyroid eye disease.
    Asaria RH; Koay B; Elston JS; Bates GE
    Eye (Lond); 1998; 12 ( Pt 6)():990-5. PubMed ID: 10326002
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Efficacy and side effects of 'swinging eyelid' orbital decompression in Graves' orbitopathy: a proposal for standardized evaluation of diplopia.
    Paridaens D; Lie A; Grootendorst RJ; van den Bosch WA
    Eye (Lond); 2006 Feb; 20(2):154-62. PubMed ID: 15746952
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Orbital volume and eye position changes after balanced orbital decompression.
    Alsuhaibani AH; Carter KD; Policeni B; Nerad JA
    Ophthalmic Plast Reconstr Surg; 2011; 27(3):158-63. PubMed ID: 20940662
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Orbital decompression for the management of thyroid eye disease: An analysis of outcomes and complications.
    Kingdom TT; Davies BW; Durairaj VD
    Laryngoscope; 2015 Sep; 125(9):2034-40. PubMed ID: 25892161
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Periphlebitis of the Superior Ophthalmic Vein.
    Lee JJ; Cohen LM; Lo CC; Rootman DB
    Ophthalmic Plast Reconstr Surg; 2021 May-Jun 01; 37(3S):S144-S148. PubMed ID: 32976333
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Antithyroglobulin monoclonal and autoantibodies cross-react with an orbital connective tissue membrane antigen: a possible mechanism for the association of ophthalmopathy with autoimmune thyroid disorders.
    Kuroki T; Ruf J; Whelan L; Miller A; Wall JR
    Clin Exp Immunol; 1985 Nov; 62(2):361-70. PubMed ID: 3841305
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Long-term follow-up of patients with thyroid eye disease treated with endoscopic orbital decompression.
    Gulati S; Ueland HO; Haugen OH; Danielsen A; Rødahl E
    Acta Ophthalmol; 2015 Mar; 93(2):178-83. PubMed ID: 24989709
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Orbital decompression for thyroid associated ophthalmopathy: transnasal endoscopic approach or external orbital approach?].
    Yang HS; Ye HJ
    Zhonghua Yan Ke Za Zhi; 2018 Jul; 54(7):484-487. PubMed ID: 29996608
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Teprotumumab (Tepezza) for Thyroid Eye Disease.
    Couch SM
    Mo Med; 2022; 119(1):36-41. PubMed ID: 36033157
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Orbital decompression in Graves' orbitopathy: efficacy and safety.
    Goh MS; McNab AA
    Intern Med J; 2005 Oct; 35(10):586-91. PubMed ID: 16207257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.